Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomised controlled trial

ISRCTN ISRCTN84128484
DOI https://doi.org/10.1186/ISRCTN84128484
Secondary identifying numbers N/A
Submission date
04/10/2004
Registration date
05/10/2004
Last edited
07/08/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Lalit Verma
Scientific

E- 18, Hudco palace
Andrews ganj
New Delhi
110049
India

Email lalitverma@yahoo.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesCentral Serous Retinopathy (CSR) is a retinal disorder affecting young adults, characterized clinically by a well-defined, translucent, circumscribed detachment of neurosensory retina at the posterior pole, usually involving the macula. The detachment results from accumulation of transparent fluid in the potential space between retinal pigment epithelial layer and the neurosensory retina.

Hypothesis:
To evaluate the efficacy of diode laser photocoagulation in patients with central serous retinopathy (CSR) and to compare it with the effects of argon green laser.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCentral Serous Retinopathy (CSR)
Intervention1. Diode Laser photocoagulation
2. Argon green laser photocoagulation
3. Fluorescein Angiography
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1998
Completion date01/06/2000

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants30
Key inclusion criteriaPatients of unilateral type 1 CSR
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/1998
Date of final enrolment01/06/2000

Locations

Countries of recruitment

  • India

Study participating centre

E- 18, Hudco palace
New Delhi
110049
India

Sponsor information

All-India Institute of Medical Sciences (AIIMS) (India)
Research organisation

Ansari Nagar
New Delhi
110029
India

Email lalitverma@yahoo.com
ROR logo "ROR" https://ror.org/02dwcqs71

Funders

Funder type

Research organisation

All-India Institute of Medical Sciences (AIIMS) (India)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 29/10/2004 Yes No